Why the study?
What is the epidemiology and genotype distribution of rotavirus gastroenteritis in Finnish children during the introduction of rotavirus vaccination?
What is the epidemiology and genotype distribution of rotavirus gastroenteritis in Finnish children during the introduction of rotavirus vaccination?
This study provides epidemiological background on rotavirus genotypes in Finland prior to universal vaccination, showing fluctuating genotype prevalence.
Answers are grounded in this paper and cite their sources.
RV genotype shifts pre-vaccination underscore surveillance needs; leaves open post-introduction impact on Finnish pediatric AGE epidemiology.
Rotaviruses (RV) are major causative agents of acute gastroenteritis (AGE) requiring hospitalization in children; RV hospitalizations may be largely eliminated by universal mass vaccination with RV vaccine. We conducted a hospital-based prospective survey of AGE in children over 2 RV epidemic seasons, from 2006 to 2008, when the coverage of RV vaccination in Finland increased to 35% of the birth cohort. RVs were detected by reverse transcription polymerase chain reaction (RT-PCR). In the first season, only 38% of AGE cases were RV-positive, and the onset of the RV season was delayed. Type G1P[8], RVs accounted for 40%, G2P[4] for 19%, G3P[8] for 2%, G4P[8] for 2% and G9P[8] for 38%. In the second season, 63% of AGE cases were RV-positive: G1P[8] accounted for 73%, G2P[4] for only 3%, G3P[8] for 4%, G4P[8] for 13%, and G9P[8] had almost disappeared. G2P[4] RV did not become predominant at the coverage level of 29% of G1P[8] human RV vaccine. RV-associated hospitalizations were seen in children up to the age of 9 y. This study forms the epidemiological background for the follow-up of the impact of universal RV vaccination in Finland introduced in 2009.
No takes yet. Share an insight, caveat, or question.
Räsänen et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: